A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
JC Polyoma Virus DNA, Qualitative, PCR, CSF : 16441
Test CodeJCCSF or 16441
Alias/See Also
JC Virus DNA, QL Real Time PCR; Polyomavirus: JCV Polyoma
CPT Codes
87798
Transport Container
Submit 0.7 mL (0.3 mL minimum) CSF collected in sterile, leak-proof container
Transport Temperature
Frozen
Specimen Stability
Room temperature: 48 hours; Refrigerated: 7 days; Frozen: 30 days
Methodology
Real-Time Polymerase Chain Reaction
Setup Schedule
Mon-Sat
Report Available
1-3 days
Limitations
Laboratory test results should always be considered in the context of clinical observations. This test was developed, and its performance characteristics determined by med fusion. It has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high complexity clinical laboratory testing.
Reference Range
Not Detected
Clinical Significance
JC Polyoma Virus (JCV) is the cause of progressive multi-focal leukoencephalopathy (PML), a demyelinating neurologic disease of immunosuppressed patients. This test detects JC polyoma virus DNA in CSF. Detection of the virus in specimens from AIDS and other severely immune compromised patients may indicate disease. Serum antibodies are not helpful in diagnosing PML as antibodies are common in the general population. JCV can also be detected in the urine of 3% of pregnant women but is not associated with proven disease.
Performing Laboratory
med fusion